Lisa M. Schiefer
Salzburg, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Asymmetric and symmetric dimethylarginine in high altitude pulmonary hypertension (HAPH) and high altitude pulmonary edema (HAPE).
Journal: Frontiers in physiology
Published: September 21, 2023
Prevalence and knowledge about acute mountain sickness in the Western Alps.
Journal: PloS one
Published: May 06, 2023
Performance and reliability of two frequently used point-of-care blood gas analyzers at 423 and 4,559 m.
Journal: Clinical biochemistry
Published: January 11, 2023
Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: May 05, 2022
Validity of Peripheral Oxygen Saturation Measurements with the Garmin Fēnix® 5X Plus Wearable Device at 4559 m.
Journal: Sensors (Basel, Switzerland)
Published: August 14, 2021
Serum neurofilament level increases after ascent to 4559 m but is not related to acute mountain sickness.
Journal: European journal of neurology
Published: July 16, 2020
Re: "Are Pre-Ascent Low-Altitude Saliva Cortisol Levels Related to the Subsequent Acute Mountain Sickness Score? Observations From a Field Study" by Gatterer et al.
Journal: High altitude medicine & biology
Published: May 09, 2020
Rapid Ascent to 4559 m Is Associated with Increased Plasma Components of the Vascular Endothelial Glycocalyx and May Be Associated with Acute Mountain Sickness.
Journal: High altitude medicine & biology
Published: March 18, 2020
Endurance Athletes Are at Increased Risk for Early Acute Mountain Sickness at 3450 m.
Journal: Medicine and science in sports and exercise
Published: December 27, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026